A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300
Journal of immunology (Baltimore, Md. : 1950) (2008) - Comments
pubmed: 18250452  issn: 0022-1767  doi: 10.4049/jimmunol.180.4.2429  issn: 1550-6606 

Aitor G. Granja, Neil D. Perkins, Yolanda Revilla